Chaoju Eye Care Holdings (HKSE:02219) ROCE % : 14.43% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Chaoju Eye Care Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chaoju Eye Care Holdings's annualized ROCE % for the quarter that ended in Jun. 2024 was 14.43%.

Chaoju Eye Care Holdings ROCE % Historical Data

The historical data trend for Chaoju Eye Care Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chaoju Eye Care Holdings ROCE % Chart

Chaoju Eye Care Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

16.29

21.60

14.05

10.08

12.19

Chaoju Eye Care Holdings Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial						11.55	9.23	15.16	9.56	14.43

Chaoju Eye Care Holdings ROCE % Calculation

Chaoju Eye Care Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	340.672	/	( ( (3040.982 - 273.576)	+	(3196.903 - 374.881) )	/ 2 )
	=	340.672	/	( (2767.406	+	2822.022)	/ 2 )
	=	340.672	/	2794.714
	=	12.19 %

Chaoju Eye Care Holdings's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	398.876	/	( ( (3196.903 - 374.881)	+	(3052.704 - 347.843) )	/ 2 )
	=	398.876	/	( ( 2822.022	+	2704.861 )	/ 2 )
	=	398.876	/	2763.4415
	=	14.43 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Chaoju Eye Care Holdings (HKSE:02219) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chaoju Eye Care Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Chaoju Eye Care Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chaoju Eye Care Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chaoju Eye Care Holdings Ltd (HKSE:02219) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 14 Yard, West 3rd Ring South Road, Block A, Shouke Building, 24th Floor, East Zone, Fengtai District, Beijing, CHN

Website

http://www.chaojueye.com

Chaoju Eye Care Holdings Ltd is a ophthalmic medical service group in North China engaged in engaged in the provision of in-patient services, out-patient services and sales of optical products. The company generate revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control and provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases.

Executives

Zhang Junfeng	2103 Interests held jointly with another person
Zhang Xiaoli	2103 Interests held jointly with another person
Zhang Bozhou	2103 Interests held jointly with another person
Areo Holdings Limited	2201 Interest of corporation controlled by you
Li Gabriel	2201 Interest of corporation controlled by you
Lam Lai Ming	2201 Interest of corporation controlled by you
Orchid Asia Vii, L.p.	2201 Interest of corporation controlled by you
Orchid Asia Vii Gp, Limited	2201 Interest of corporation controlled by you
Orchid Asia V Group, Limited	2201 Interest of corporation controlled by you
Orchid Asia V Group Management, Limited	2201 Interest of corporation controlled by you
Oavii Holdings, L.p.	2201 Interest of corporation controlled by you
Orchid Asia Vii Global Investment Limited	2101 Beneficial owner
Wang Stephen Hui	2201 Interest of corporation controlled by you
Xia Men Chao Xi Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Zhang Wenwen	2201 Interest of corporation controlled by you

Chaoju Eye Care Holdings Headlines

No Headlines